---
title: "Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293075631.md"
description: "Charles River Laboratories International Inc. (CRL) shares fell 2.10% to $224.35 on Friday, underperforming the broader market and some competitors. While Labcorp and Bio-Techne rose slightly, Alnylam Pharmaceuticals dropped significantly. CRL closed 5.68% below its 52-week high of $237.86. Trading volume was notably lower than the 50-day average."
datetime: "2026-07-17T21:16:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293075631.md)
  - [en](https://longbridge.com/en/news/293075631.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293075631.md)
---

# Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. (CRL) slid 2.10% to $224.35 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.

Charles River Laboratories International Inc. closed 5.68% short of its 52-week high of $237.86, which the company achieved on July 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Labcorp Holdings Inc. (LH) rose 0.50% to $283.36, Alnylam Pharmaceuticals Inc. (ALNY) fell 5.54% to $267.47, and Bio-Techne Corp. (TECH) rose 0.49% to $72.12.

Trading volume (708,374) remained 208,203 below its 50-day average volume of 916,577.

Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-17-26 1716ET

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LH.US](https://longbridge.com/en/quote/LH.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)

## Related News & Research

- [Amundi Increases Stake in Charles River Laboratories International, Inc. $CRL](https://longbridge.com/en/news/294574425.md)
- [Charles River Laboratories Earnings Preview: What to Expect](https://longbridge.com/en/news/293235736.md)
- [Charles River Laboratories International (CRL) Expands AI Pathology Platform, Is The Valuation Upside Already Priced In?](https://longbridge.com/en/news/292410138.md)
- [Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors](https://longbridge.com/en/news/288906897.md)
- [Norges Bank Takes $96.77 Million Position in Charles River Laboratories International, Inc. $CRL](https://longbridge.com/en/news/288927524.md)